Acute interferon β-1b administration alters hypothalamic-pituitary-adrenal axis activity, plasma cytokines and leukocyte distribution in healthy subjects
- 30 November 2002
- journal article
- Published by Elsevier BV in Psychoneuroendocrinology
- Vol. 27 (8), 881-892
- https://doi.org/10.1016/s0306-4530(01)00099-3
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Acute interferon-α administration modulates sucrose consumption in the ratPsychoneuroendocrinology, 2001
- Interferon-β treatment in multiple sclerosis patients decreases the number of circulating T cells producing interferon-γ and interleukin-4Journal of Neuroimmunology, 2000
- Multiple SclerosisNew England Journal of Medicine, 2000
- SHORT-TERM TREATMENT OF RELAPSING REMITTING MULTIPLE SCLEROSIS PATIENTS WITH INTERFERON (IFN)-β1B TRANSIENTLY INCREASES THE BLOOD LEVELS OF INTERLEUKIN (IL)-6, IL-10 AND IFN-γ WITHOUT SIGNIFICANTLY MODIFYING THOSE OF IL-1β, IL-2, IL-4 AND TUMOUR NECROSIS FACTOR-αCytokine, 2000
- Effect of IFNβ and anti-IFNβ antibodies on NK cells in multiple sclerosis patientsJournal of Neuroimmunology, 2000
- Changes in plasma cytokines induced by interferon-β1a treatment in patients with multiple sclerosisJournal of Neuroimmunology, 1999
- Amelioration of flulike symptoms at the onset of interferon β‐ 1b therapy in multiple sclerosis by low‐dose oral steroids is related to a decrease in interleukin‐6 inductionAnnals of Neurology, 1998
- The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated InflammationNew England Journal of Medicine, 1995
- Effects of Cytokines on the Pituitary–Adrenal Axis in Cancer PatientsJournal of Interferon Research, 1993
- Human Fibroblast Interferon for Clinical Trials: Pharmacokinetics and Tolerability in Experimental Animals and HumansAntimicrobial Agents and Chemotherapy, 1979